European mid-market private equity firm Inflexion is to sell its investment in Lintbells, a specialist in pet supplements which are sold under the YuMOVE brand name, to to Vetnique Labs, a portfolio company of Gryphon Investors.
The sale marks a highly successful exit for Inflexion Enterprise Fund IV, generating a 5.5x return.
Hertfordshire, UK-based Lintbells was founded almost two decades ago by Dr John Howie DL and John Davies, to provide pets and their owners with scientifically supported supplements to support chronic health conditions. Lintbells’ YuMOVE products a joint mobility supplements for dogs and cats, as well as supplements to support digestive health, anxiety, skin & coat and dental.
Since the 2017 investment, Inflexion’s in-house teams have supported Lintbells across a range of growth opportunities, including its expansion of the highly successful direct-to-consumer channel. Inflexion has also supported the successful expansion of Lintbells into the US both organically and through the acquisition of Walkin’ Pets.
In addition to Lintbells, Inflexion has significant experience in the pet-care market with previous successful investments including Medivet and Kynetec.
Can’t stop reading? Read more
DN Capital and CommerzVentures lead $30m investment in AI firm Unique
DN Capital and CommerzVentures lead $30m investment in AI firm Unique Tech firm Unique secured...
KKR invests in Family Doctor with $300m deal to fuel expansion
KKR invests in Family Doctor with $300m deal to fuel expansion Private equity giant KKR acquired a...
Update: BlackRock completes acquisition of Preqin to strengthen private markets capabilities
Update: BlackRock completes acquisition of Preqin to strengthen private markets capabilities...